Valeant Pharmaceuticals Announces Collaboration Between Bausch + Lomb And IBM
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Valeant (VRX) Derm NRx Up 2.2% Week-over-Week - RBC Capital
May 6, 2016 8:44 AM EDTRBC Capital analyst Douglas Miehm noted Valeant Pharmaceuticals (NYSE: VRX) Derm NRx increased 2.2% WoW, ophth NRx were up 2.7% WoW, and Addyi NRx were down 16.2% WoW.
"For the week ending April 29th, new derm scripts (NRx) were up 2.2% vs. down 2.9% the prior week," Miehm commented. "NRx this week... More
